Seattle startup Cyrus inks protein-design deal with immune biotech Selecta worth up to $1.5 billion
Cyrus Biotechnology has several drug discovery and development partnerships and also markets Cyrus Bench, a software platform for protein engineering. (Cyrus photo) Seattle-based Cyrus Biotechnology is entering into a protein …